Covecell Labs is an execution-driven platform integrating process development, analytics, and CMC tech transfer—engineered to reduce development timelines without compromising quality or clinical readiness.
From upstream cell culture to downstream purification — we design, optimize, and scale your bioprocessing workflows for clinical and commercial success.
Robust assay development and qualification for cell viability, potency, identity, purity, and safety — aligned with ICH and FDA/EMA regulatory standards.
Seamless technology transfer to CDMOs and manufacturing sites. We prepare your CMC documentation, process validation protocols, and regulatory submissions.
Our proprietary AI models analyze process parameters in real time, reducing development timelines and identifying critical quality attributes faster — compressing process validation and tech transfer cycles.
We deliver the same rigorous, GMP-ready output you'd expect from top-tier CROs — at significantly faster turnaround times and a fraction of the cost. No compromises on science, just smarter execution.
Our team brings hands-on experience with viral vectors, CAR-T, TCR-T, iPSCs, HSPC, and NK cell platforms.
We leverage machine learning to compress timelines, cut costs, improve process robustness, and reduce tech transfer timelines.
Every deliverable is structured for IND, BLA, and MAA submissions.
From standalone analytical projects to full CMC programs — we scale to your needs and budget.
We understand your therapy, stage of development, and regulatory pathway.
We design a tailored scope of work with clear milestones and deliverables.
Our scientists execute with precision — AI tools monitoring quality at every step.
You receive complete technical reports, raw data, and CMC-ready documentation.
"Covecell Labs compressed our process development timeline by 40%. Their AI tools identified critical parameters we would have missed for months."
"Exceptional analytical development support. Their team had our potency assay qualified and ready for IND in record time."
We are a science-first bioprocessing company on a mission to make cell and gene therapies accessible to patients faster.
Founded by experts in end-to-end bioprocessing, CMC, and regulatory development, Covecell Labs was built to solve one of biotech's hardest problems: getting promising therapies from the lab to the clinic — reliably, rapidly, and cost-effectively.
We combine deep domain expertise in cell and gene therapy manufacturing with proprietary AI tools that optimize processes, predict failure modes, and compress timelines. Our team has supported programs across CAR-T, TCR-T, viral vectors, stem cells, and NK cell platforms.
To accelerate the development of life-saving cell and gene therapies through intelligent bioprocessing and rigorous analytical science.
A world where no therapy fails due to manufacturing or CMC challenges.
Engineered to maximize value at every stage — from early-phase process development to commercial tech transfer, Covecell Labs delivers end-to-end CMC support that accelerates timelines and reduces total program costs for cell and gene therapy programs.
End-to-end upstream and downstream process design, optimization, and scale-up for cell and gene therapy products.
Comprehensive assay development and method qualification for regulatory submissions.
Seamless technology transfer with complete regulatory documentation support.
Machine learning-driven process intelligence for faster, smarter development.
We support a wide range of cell and gene therapy modalities including CAR-T cells, TCR-T cells, NK cells, stem cells (iPSC, MSC), viral vectors (AAV, lentivirus), and gene-edited cell products.
Yes. We work with companies at all stages — from academic spinouts filing their first IND to established biotechs preparing for commercial launch.
Our analytical and process development work is designed to be GMP-ready. We partner with GMP-certified CDMOs for manufacturing execution when required.
Our AI tools analyze historical and real-time process data to identify optimal parameters, predict quality deviations, and reduce the number of experiments needed — saving time and cost.
Timelines vary by scope. A standalone assay development project may take 6–12 weeks. A full process development and CMC package typically runs 2–9 months depending on complexity.
Yes. We prepare CMC sections for IND and BLA submissions and can support agency meetings and responses to regulatory questions.
Simply reach out via our contact form or email info@covecell.com. We'll schedule a free 30-minute discovery call to understand your needs.
We're building a team of scientists, engineers, and problem-solvers who want to accelerate life-saving therapies. If that sounds like you, we'd love to hear from you.
Your work directly accelerates cell and gene therapies reaching patients who need them — every project has real clinical significance.
Join early and shape the company. You'll wear multiple hats, solve hard problems, and grow faster than at a large organization.
We value transparency, scientific rigor, and mutual respect. Every voice matters — from intern to co-founder.
Competitive salary, equity participation, flexible work arrangements, and the opportunity to build something from the ground up.
Lead upstream and downstream process development for cell therapy products. Experience in mammalian cell culture, bioreactor operation, and process scale-up required. Experience with CAR-T or viral vector manufacturing preferred.
Apply NowDevelop and qualify analytical methods for cell therapy characterization including flow cytometry, ELISA, qPCR, and potency assays. 3+ years of experience in a GMP or GMP-ready environment preferred.
Apply NowDesign and build AI-powered tools and predictive models for bioprocess applications. Develop data pipelines, automation workflows, and intelligent platforms that accelerate drug development timelines. Strong Python/ML background required. Biotech domain experience is a plus but not required.
Apply NowWhether you have a specific project in mind or just want to explore how we can help — we'd love to hear from you.
Reach out directly — our team typically responds within 1 business day.